Siderophores: a potential role as a diagnostic for invasive fungal disease

Lisa Kriegl1, Vladimir Havlicek2,3, Karl Dichtl4

  • 1Division of Infectious Diseases, Department of Internal Medicine, ECMM Excellence Center Diamond Status, Medical University of Graz, Graz, Austria.

Abstract

Insights

Siderophores, iron-chelating molecules produced by fungi, show promise as biomarkers for diagnosing invasive fungal diseases like invasive aspergillosis. Detecting specific siderophores such as triacetylfusarinine C (TAFC) in patient samples could significantly improve early and accurate diagnosis.

Area of Science:

  • Mycology
  • Medical Diagnostics
  • Biochemistry

Background:

  • Invasive fungal diseases (IFDs), particularly invasive aspergillosis, pose significant diagnostic challenges and are linked to high mortality rates.
  • Siderophores, high-affinity iron chelators produced by fungi, are being explored as novel diagnostic targets for IFDs.
  • Previous research has investigated siderophores as therapeutic targets in mucormycosis.

Approach:

  • This review examines the diagnostic potential of siderophores for IFDs, focusing on invasive aspergillosis.
  • It discusses the detection of Aspergillus fumigatus siderophore, triacetylfusarinine C (TAFC), in patient samples (serum, BALF, urine) using mass spectrometry.
  • The review also covers the use of siderophores conjugated with radioisotopes for diagnostic imaging (PET) and markers for Scedosporium apiospermum.

Key Points:

  • Triacetylfusarinine C (TAFC) has demonstrated promising sensitivity and specificity in preliminary studies for diagnosing invasive aspergillosis.
  • Gallium-68 (68Ga)-conjugated siderophores offer potential for in vivo imaging of fungal infections.
  • N(α)-methyl coprogen B shows potential as an early marker for airway colonization by Scedosporium apiospermum.

Conclusions:

  • Siderophores, especially TAFC, hold the potential to transform diagnostic strategies for invasive aspergillosis and other mould infections.
  • Larger, multicenter studies are required to validate the diagnostic performance of siderophores.
  • Development of rapid, cost-effective methods for routine clinical use, particularly for TAFC detection, is crucial.